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Thank you Dr. Nataraj, Dr. Maiya, and Dr.
Nagaraju for your response.
Although we have focused on US guidelines
surrounding chronic kidney disease (CKD) in
people with type 2 diabetes mellitus, this is
clearly a global issue. We recognize that the
standard of care in the USA may differ from
other countries. The goal of frequent kidney
function screening in people with diabetes is to
prevent patients from presenting with gross
symptoms of CKD as in the example given.
We agree that prevention is key. We look
forward to learning more about the role of
exercise in CKD prevention as further research
develops. The guidelines we presented and
medications described to help prevent and slow
progression of CKD are reliant on access to
resources in the community. Unfortunately,
there are many obstacles including costs, access
to specialists, health literacy, and patient nonadherence. However, we must advocate for our
patients to prevent the long-term consequences
of CKD.
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